You're spending $400/month on tirzepatide through a telehealth platform. That's $4,800 a year. Your HSA has room in it. Your accountant mentioned something about medical expenses being deductible. Your buddy said you can use FSA dollars for Ozempic. Different people are giving you different answers, and you're not sure what actually qualifies.
Here's the honest breakdown of HSA and FSA eligibility for GLP-1 medications — what's covered, what isn't, how to document it so your administrator approves the reimbursement, and the pitfalls that men run into with weight-loss-adjacent expenses.
Baseline rules
Under IRS Publication 502, medical expenses that qualify for HSA, FSA, and HRA reimbursement must be for the "diagnosis, cure, mitigation, treatment, or prevention of disease." Prescription medications are generally qualifying — but the IRS has historically carved out "general health" and "cosmetic" purposes.
For GLP-1s, the key question has been whether the medication is prescribed for a qualifying medical condition (Type 2 diabetes, obesity with comorbidities, cardiovascular risk) or for "general weight loss." The IRS has been clear: weight loss for general wellness is not a qualified medical expense. Weight loss treatment for diagnosed obesity, with physician documentation, is.
What qualifies
- GLP-1s prescribed for Type 2 diabetes (Ozempic, Mounjaro, Trulicity, Rybelsus). Clearly qualifying — no extra documentation usually needed beyond the prescription receipt.
- GLP-1s prescribed for obesity with documented BMI ≥30. Qualifying as treatment for the disease of obesity.
- GLP-1s prescribed for overweight (BMI 27–29.9) with qualifying comorbidity (hypertension, dyslipidemia, Type 2 diabetes, sleep apnea, cardiovascular disease). Qualifying with physician's letter documenting the comorbidity.
- GLP-1s prescribed specifically for cardiovascular risk reduction (after SELECT trial indication). Qualifying as treatment for a diagnosed cardiovascular condition.
- Related medical expenses: telehealth visits, in-person physician consultations, lab work, injection supplies, sharps containers.
What typically doesn't qualify
- GLP-1s for "vanity weight loss" — men with normal BMI who want cosmetic fat loss. Not qualifying.
- GLP-1s without physician documentation. You need the underlying diagnosis in your records, not just a receipt.
- Supplements and over-the-counter products marketed alongside GLP-1s. Amazon supplements to support your protocol are generally not qualifying unless a physician specifies them as treatment.
- Gym memberships or fitness equipment purchased alongside the protocol. Even if part of a weight-loss plan, these remain non-qualifying unless specifically prescribed for a medical condition.
- Food and meal delivery services that support the protocol.
- Cosmetic procedures related to post-weight-loss loose skin (panniculectomy may qualify if documented as medically necessary due to recurring rashes/infections; pure cosmetic procedures do not).
The documentation trail that gets you approved
What to keep in your records
- Prescription receipt with medication name, date, prescriber, and your name.
- A "Letter of Medical Necessity" (LMN) from your prescriber. Especially important for weight management indications. Template should include: your diagnosis code (ICD-10), height/weight/BMI, relevant comorbidities, medical rationale for the prescription, and expected duration of treatment.
- Your BMI or relevant lab values documented. Keep a copy of the initial intake evaluation that establishes the qualifying condition.
- Pharmacy receipts with the medication name and NDC number. Some telehealth platforms provide consolidated billing statements — these are cleaner.
- Telehealth visit receipts that include your diagnosis and the prescription.
- Annual summary of all HSA/FSA-eligible spending. Most good administrators let you upload receipts once per transaction.
HSA vs. FSA: the differences that matter for GLP-1 use
| Feature | HSA | FSA |
|---|---|---|
| 2026 contribution limit (single) | $4,400 | $3,300 |
| 2026 contribution limit (family) | $8,750 | $3,300 |
| Rollover | Full rollover year-to-year | $660 max rollover (or grace period) |
| Requires HDHP plan? | Yes | No |
| Portability | Stays with you job-to-job | Tied to employer |
| Investment growth | Yes, tax-free | No |
| Suited for GLP-1? | Very — long-term medication | Yes, if annual cost can be predicted |
For a man planning to be on GLP-1 therapy for multiple years, HSA is the better vehicle when available — the rollover and investment growth compound the tax benefit over time. FSA works but forces annual use-it-or-lose-it decisions that don't fit chronic medication well.
How to actually use HSA/FSA for GLP-1
Option 1: HSA/FSA debit card at point of sale
Many pharmacies accept HSA/FSA cards directly. Walmart, Costco, Walgreens, and CVS all process these at checkout. For brand-name GLP-1s dispensed at these pharmacies, this is the cleanest approach — tax-advantaged dollars paid directly for the medication, automatic record creation.
Option 2: Pay out of pocket, submit for reimbursement
Pay with regular debit/credit, save the receipt, submit to your administrator for reimbursement. This works for most telehealth platforms that don't accept HSA/FSA cards directly. Straightforward but adds paperwork.
Option 3: Direct billing where supported
A small number of telehealth platforms now accept HSA/FSA directly. Ask at intake. If yes, the process mirrors in-person pharmacy — no paperwork on your end.
Option 4: TrumpRx direct-to-consumer
As of 2026, TrumpRx provides direct-to-consumer access to brand-name GLP-1s at reduced prices ($199–$350/month for Wegovy/Ozempic, $299/month for Zepbound).1 These purchases can be HSA/FSA eligible with proper documentation — but be aware that TrumpRx purchases may not automatically count toward your insurance plan's deductible, which can change the tax math for people with high-deductible plans.
Compounded GLP-1s and HSA/FSA: the gray area
Compounded semaglutide and tirzepatide occupy a regulatory gray zone. After FDA shortage declarations resolved for brand-name products in 2024–2025, compounded GLP-1 availability tightened. Whether compounded versions qualify for HSA/FSA depends on: (1) whether they're prescribed for a qualifying medical condition, (2) whether the compounding pharmacy is legitimate, (3) whether the administrator accepts compounded products. Most HSA/FSA administrators do accept prescription compounded medications with proper documentation — but some flag them for review. Keep thorough records and be prepared to provide the LMN if questioned.
The annual planning math
If you plan to spend $3,600–$6,000/year on GLP-1 therapy, tax-advantaged dollars save you meaningful money. Example for a man in the 22% federal bracket + 5% state:
- $4,800 annual spending without HSA: costs $4,800 after-tax dollars.
- $4,800 annual spending with HSA: costs $4,800 pre-tax dollars (~$6,575 pre-tax equivalent, since you'd need $6,575 in gross income to end up with $4,800 after tax).
- Tax savings: approximately $1,775/year.
For a man in higher brackets (32% + state), HSA savings are $2,500+/year. Over 5 years of GLP-1 therapy, that's $12,500+ in tax savings — real money.
What the reimbursement process actually looks like
Typical workflow after paying out of pocket:
- Log into HSA/FSA administrator portal (HealthEquity, Fidelity, Optum, Payflex, etc.).
- Click "Submit claim" or "Request reimbursement."
- Enter date of service, amount, provider name, type of expense.
- Upload pharmacy receipt (PDF or photo).
- Upload LMN if requested (most administrators don't ask on every claim — they ask when flagged).
- Submit.
- Reimbursement typically hits your linked bank account in 1–5 business days.
Tips to avoid delays: receipts must show the medication name, not just "prescription filled." LMN should be current (typically within the last 12 months). Keep copies of everything — administrators sometimes audit.
Common mistakes
- Using HSA/FSA for compounded products from non-pharmacy "wellness" sources. If the source isn't a licensed pharmacy, the product likely isn't a qualified prescription medication.
- Including gym, supplements, and meal services in the claim. These are separate issues — don't bundle them with legitimate prescription reimbursements.
- Missing LMN documentation. Weight-loss-indicated GLP-1 claims get flagged more often than diabetes-indicated claims. Have the LMN ready.
- Submitting handwritten receipts without medication names. Administrator will reject. Get official pharmacy documentation.
- Submitting after the deadline. Most plans allow 60–90 days for claim submission. Don't sit on receipts.
- Double-dipping. Don't submit the same expense to both HSA and tax return as itemized medical expense. One or the other.
What to ask your telehealth provider
Before choosing a telehealth platform for long-term GLP-1 care, ask:
- "Do you provide itemized receipts that include the medication name?"
- "Do you support HSA/FSA direct payment at checkout?"
- "Will my prescribing physician provide a Letter of Medical Necessity on request?"
- "What documentation do you provide for year-end HSA/FSA review?"
- "Is your compounding pharmacy an outsourcing facility (503B) or traditional compounding (503A)?"
Platforms that can answer these cleanly are easier to work with for long-term tax-advantaged management.
Providers that support clean HSA/FSA documentation
Platforms with physician-supervised programs and itemized clinical documentation make the HSA/FSA reimbursement process straightforward. Budget-friendly options with real clinical infrastructure are the sweet spot.
Check Yucca Health Eligibility → Yucca Health offers affordable GLP-1 programs with clinical support. Prefer brand-name FDA-approved prescriptions for cleaner documentation? Sesame Care via licensed US physicians. Want rigorous physician-led care? Synergy Rx.The bottom line
HSA and FSA dollars can substantially reduce the out-of-pocket cost of long-term GLP-1 therapy — typically saving $1,500–$2,500/year in tax-advantaged benefit for men spending $4,000–$6,000 annually on medication.
The keys: prescription for a qualifying medical condition (diabetes or obesity with documentation), proper paperwork trail (prescription receipt + LMN when asked), and clean telehealth platform documentation that holds up to administrator review.
For men planning to stay on GLP-1 therapy long-term (which is increasingly the default for obesity as a chronic condition), running the costs through an HSA is the smart play. Over 5–10 years of therapy, tax-advantaged savings compound to real money — money that covers meaningful fractions of the medication itself.
This is not tax advice. Consult a tax professional about your specific situation, and always confirm with your HSA/FSA administrator before assuming an expense is qualifying.
References
- AJMC. Trump Announces Deals With Lilly, Novo to Cut Weight Loss Drug Prices. April 2026.
- IRS Publication 502. Medical and Dental Expenses. Current revision.
- IRS Publication 969. Health Savings Accounts and Other Tax-Favored Health Plans. Current revision.